Novozymes A/S NZM.F Stock
Novozymes A/S Price Chart
Novozymes A/S NZM.F Financial and Trading Overview
| Novozymes A/S stock price | 51 EUR |
| Previous Close | 45.8 EUR |
| Open | 45 EUR |
| Bid | 45 EUR x N/A |
| Ask | 46.2 EUR x N/A |
| Day's Range | 45 - 45 EUR |
| 52 Week Range | 43.2 - 63 EUR |
| Volume | 50 EUR |
| Avg. Volume | 3 EUR |
| Market Cap | 12.59B EUR |
| Beta (5Y Monthly) | 0.431034 |
| PE Ratio (TTM) | 26.16279 |
| EPS (TTM) | 1.46 EUR |
| Forward Dividend & Yield | 0.79 (1.77%) |
| Ex-Dividend Date | March 6, 2023 |
| 1y Target Est | N/A |
NZM.F Valuation Measures
| Enterprise Value | 20.1B EUR |
| Trailing P/E | 26.16279 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.70683986 |
| Price/Book (mrq) | 0.967513 |
| Enterprise Value/Revenue | 1.129 |
| Enterprise Value/EBITDA | 3.481 |
Trading Information
Novozymes A/S Stock Price History
| Beta (5Y Monthly) | 0.431034 |
| 52-Week Change | -14.71% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 63 EUR |
| 52 Week Low | 43.2 EUR |
| 50-Day Moving Average | 46.46 EUR |
| 200-Day Moving Average | 49.09 EUR |
NZM.F Share Statistics
| Avg. Volume (3 month) | 3 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 276.6M |
| Float | 194.53M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.050% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 6 |
| Trailing Annual Dividend Yield | 13.10% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4578 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 20.37% |
| Operating Margin (ttm) | 25.49% |
| Gross Margin | 54.28% |
| EBITDA Margin | 32.43% |
Management Effectiveness
| Return on Assets (ttm) | 10.59% |
| Return on Equity (ttm) | 29.22% |
Income Statement
| Revenue (ttm) | 17.81B EUR |
| Revenue Per Share (ttm) | 64.37 EUR |
| Quarterly Revenue Growth (yoy) | 5.80% |
| Gross Profit (ttm) | 9.59B EUR |
| EBITDA | 5.78B EUR |
| Net Income Avi to Common (ttm) | 3.63B EUR |
| Diluted EPS (ttm) | 1.72 |
| Quarterly Earnings Growth (yoy) | -5.80% |
Balance Sheet
| Total Cash (mrq) | 1.1B EUR |
| Total Cash Per Share (mrq) | 3.97 EUR |
| Total Debt (mrq) | 8.28B EUR |
| Total Debt/Equity (mrq) | 62.31 EUR |
| Current Ratio (mrq) | 1.348 |
| Book Value Per Share (mrq) | 46.511 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 3.54B EUR |
| Levered Free Cash Flow (ttm) | 449.12M EUR |
Profile of Novozymes A/S
| Country | Germany |
| State | N/A |
| City | Bagsvaerd |
| Address | Krogshoejvej 36 |
| ZIP | 2880 |
| Phone | 45 44 46 00 00 |
| Website | https://www.novozymes.com |
| Industry | Specialty Chemicals |
| Sector(s) | Basic Materials |
| Full Time Employees | 6790 |
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers baking, beverages, dairy, starch, and protein solutions for the food and beverage industry; laundry, dishwashing, and professional cleaning solutions for the household care industry; agriculture solutions, including crop production, and animal health and nutrition solutions; bioyield and biocontrol solutions for crops; and grain and technical processing solutions, as well as bio energy solutions for liquefaction, saccharifaction, fermentation, fiber conversion, and biomass conversion. It also provides textile solutions, such as biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing solutions. In addition, the company offers solutions for pulp & paper, including fiber modification, bleach boosting, deposit control, starch modification, and deinking; leather solutions comprising acid bating, area expansion, bating, degreasing, soaking, and unhairing and liming; and water and waste management solutions, which consist of bioaugmentation, biogas, and sludge management. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis, as well as rTrypsin for cell culture; and human health and protein solutions. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novozymes A/S Stock
What is a current NZM.F stock price?
Novozymes A/S NZM.F stock price today per share is 51 EUR.
How to purchase Novozymes A/S stock?
You can buy NZM.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novozymes A/S?
The stock symbol or ticker of Novozymes A/S is NZM.F.
Which industry does the Novozymes A/S company belong to?
The Novozymes A/S industry is Specialty Chemicals.
How many shares does Novozymes A/S have in circulation?
The max supply of Novozymes A/S shares is 468.69M.
What is Novozymes A/S Price to Earnings Ratio (PE Ratio)?
Novozymes A/S PE Ratio is 34.93150700 now.
What was Novozymes A/S earnings per share over the trailing 12 months (TTM)?
Novozymes A/S EPS is 1.46 EUR over the trailing 12 months.
Which sector does the Novozymes A/S company belong to?
The Novozymes A/S sector is Basic Materials.